REFERENCES:
1.Verma. R K, Garg S; Current status of drug delivery technologies and future directions. Pharm Technol. 2001; 25:1-14.
2.Theeuwes F, Swanson D R, Guitttard G, Ayer A, Khanna S; Osmotic delivery systems for the β-adrenoceptor antagonists Metoprolol and Oxprenolol: Design and evaluation of systems for once-daily administration. Br. J Clin Pharmacology. 1985; 19, 69-76.
3.Santus G, Baker R W; Osmotic drug delivery: A review of the patent literature. J Control Release, 1995, 35, 1-21.
4.Verma R K, Mishra B, Garg S; Osmotically controlled oral drug delivery. Drug Dev Ind Pharm. 2000; 26(7):695-708.
5. Prescott L F; The need for improved drug delivery in clinical practice, In: Novel Drug Delivery and Its Therapeutic application, John Wiley and Sons, West Susset, UK, 1989, 1-11.
6.Dr Bhatt P P; Osmotic drug delivery systems for poorly water soluble drugs Pharmaventures Ltd., Oxford, UK, 2004; 26-29
7.Pfefer, W E P; Osmotishe Umtersuchen, Leipzig. 1877; 232
8.Li X and Jasti B R; Osmotic controlled drug delivery systems, In: Design of controlled release of drug delivery systems, McGraw Hill, 2006; 203-229.
9. Rastogi S K, Vaya N, Mishra B; Osmotic pump: A novel concept in rate controlled oral drug delivery. Eastern pharmacist. 1995; (38):79-82.
10.Fix J, In: Encyclopedia of controlled drug delivery, Edmathiowitz, vol-2, John Wiley and sons, Inc 700.
11. Kaushal A M and Garg S; An update on osmotic drug delivery patents, Pharm Tech. Aug 2003; 38-44.
12.Lachman L., Liberman H. A., Kanig J. L., The theory and practise of industrial pharmacy. 2nd Edition 1991, Varghese publishing house, P=455
13.Stuti G, Ravindra PS, Rohitashva S. International Journal of Comprehensive Pharmacy 2011; 6: 1.
14.NK Jain. Advances in controlled and novel drug delivery, CBS Publisher & distributer, first adition. Page No.20
15.Theuwes F., Swanson D. R., Guitttard G. and Ayer A. (1985). Br. J.Clin. Pharmacology, 19, 69-76.
16.Parashar Bharat, Maurya Brajesh, Yadav Virendra, Sharma Love. “A review on osmotically regulated devices.” The pharma innovation.2012; 1(4):48-56.
17.Gadwal P, Rudrawal P. International Journal of Pharmacy & Life Sciences 2010; 1(6): 302-312.
18.Ouyang D, Nie S, Li W, Guo H, Liu H, Pan W. J Pharm Pharmacol 2005; (57): 817-820.
19.Tanmoy Ghosh, Amitava Ghosh. Journal of Applied Pharmaceutical Science 2011; 1 (2): 38-49
20.F Theeuwes. Journal of Pharmaceutical Sciences 1975; (64): 1987– 1991.
21.Mane Suraj S., Kamble Meghana S., Chaudhari Pravin D., Bhosale Ashok V., “A review on oral osmotically controlled drug delivery system.” International J. Of universal pharmacy and life sciences (IJUPLS).2012; 2(2):19-36
22.Parma NS, Vyas SK, NK Jain. In: Advanced in controlled and novel drug delivery. CBS publisher, 28-29.
23.Dong L, Shafi K, Wan J, Wong; In: Proceeding of the international symposium on controlled release of bioactive material, paris (july) 2003.
24.Cortese R and Theeuwes F; Osmotic device with hydro gel driving member. US Patent 4327725; 1982.
25.Javad Shokri, Parinaz Ahmadi, Parisa Rashidi, Mahbobeh Shahsavari, Ali Rajabi-Siahboomi, Ali Nokhodchi. European Journal of Pharmaceutics and Biopharmaceutics 2008; 68: 289–297.
26.Gaylen Zentner M, Gerald S Rork and Kenneth J Himmerstein; The Controlled Porosity Osmotic Pump. J Control Rel. 1985: 1: 269-282.
27.Kaushal, Aditya and Garg Sanjay. Pharma Technol 2003; 27: 39.
28.Theeuwes F, Wong P S L, Burkoth T L and Fox D A; Osmotic systems for colon-targeted drug delivery. In: Colonic drug absorption and metabolism. Marcel Dekker, NY, 1993; 137-158.
29.Longxiao Liu, Jeong Ku, Gilson Khang, Bong Lee, John M Rhee, Hai Bang Lee. Journal of Controlled Release 2000; 68: 145–156.
30.Patel Harnish, Patel Upendra, Kadikar Hiren, Bhimani Bhavin, Daslaniya Dhiren, Patel Ghanshyam. “A review on osmotic drug delivery system.” International research J. Of pharmacy (IRJP).2012; 3(4):88-94.
31.Wong P S I, Barclay B, Deters J C and Theeuwes F; Osmotic device with dual thermodynamic activity. US Patent 4612008; 1986.
32.Ghosh Tanmoy, Ghosh Amitava. “A review on drug delivery through osmotic systems.” J. Of applied pharmaceutical science (JAPS).2011; 01(02):38-49.
33. Sudeesh E: Formulation development and optimization of controlled porosity osmotic pump tablets of diclofenac sodium. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3(1): 80-87.
34.Prakash RB, Geetha M, Purushothama N, Utpal S: Optimization and Development of Swellable Controlled Porosity Osmotic Pump Tablet for Theophylline. Tropical Journal of Pharmaceutical Research 2009; 8(3) 247-255.
35.Nikam PH, Kareparamban, Jadhav AP, Kadam VJ., “A review on osmotic pump: A Reliable drug delivery system. Research J. Of pharmaceutical, Biological Chemical Sciences (RJPBCS).2012; 3(3):478-493.
36.Mahalaxmi R, Phanidhar S, Ravikumar, Atin K, Pritam K, Narkhede: Enhancement of Dissolution of Glipizide from Controlled Porosity Osmotic Pump Using a Wicking Agent and a Solubilizing Agent International Journal of PharmTech Research 2009;13): 705
37.GM Zentner, GS Rork, KJ Himmelstein. US patent 4, 1990,968,507
38.Gaebler F; Laser drilling enables advanced drug delivery systems, Coherent article for Pharmaceutical Manufacturing, Jan-2007, 1-7.
39.Speers M, Bonnano C. Economic aspects of controlled drug delivery. In: Mathiowitz E,
ed. Encyclopedia of Controlled Drug Delivery. New York, NY: Wiley; 1999:341Y347
40.Eckenhoff, Yum SI: The osmotic pump: novel research tool for optimizing drug regimen. Biomaterials, 1981; 2:89-97
.png)
